FdaApplication
ANDA 207516
Identifiers
- fda_app_no: ANDA207516
Properties
| Property | Value |
|---|---|
| applicant_name | HANGZHOU MINSHENG BINJIANG PHARMACEUTICAL CO LTD |
| application_type | ANDA |
| approval_date | 2019-02-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | 35MG | TABLET;ORAL |
1 product